Status | Study |
Recruiting |
Study Name: Comparison Between Corticosteroid and Topical Steroids in the DRESS Condition: Drug Rash With Eosinophilia and Systemic Symptoms Date: 2013-09-17 Interventions: Drug: Prednisone |
Recruiting |
Study Name: Testing the Effectiveness of Henna on Managing PPE Condition: Palmar-plantar Erythrodysesthesia (PPE) Date: 2012-12-14 Interventions: Drug: Henna Drug: Placebo |
Completed |
Study Name: Effectiveness Allopurinol Topical Agent Prevention Capecitabine-induced Hand-foot Syndrome Condition: Hand-foot Syndrome Date: 2012-05-24 Interventions: Drug: Allopurinol Allopurinol |
Completed |
Study Name: Extended Open Challenge in Patients With a History of Drug Eruption Following Beta-lactam Treatment Condition: Beta-lactam Allergy Date: 2011-11-20 Interventions: Drug: Beta-lactam oral challenge Oral daily dose, according to patient's weight, of amoxicillin or other |
Withdrawn |
Study Name: Prevention of Drug Rash From Certain Cancer Therapies Using Tretinoin Cream Condition: Medication Reaction Date: 2011-05-05 Interventions: Drug: Tretinoin tretinoin 0.025% cream |
Completed |
Study Name: Safety and Efficacy Placebo Controlled Study of ATH008 Cream in PPES Patients Secondary to Capecitabine Condition: Palmar-Plantar Erythrodysesthesia Syndrome Date: 2011-03-14 Interventions: Drug: ATH008 The subject will be incorporated in the study and randomised to ATH008 cream 3% or 8% or AT |
Recruiting |
Study Name: Prevention of Capecitabine Induced Hand and Foot Syndrome Condition: Cancer Date: 2011-02-07 Interventions: Device: socks containing copper-oxide fibers The patients will use a sock which contains copper fibers. |
Completed |
Study Name: Treatment of Palmar Plantar Erythrodysesthesia (PPE) With Topical Sildenafil Condition: Hand Foot Syndrome Palmar Plantar Erythrodysesthesia Date: 2010-10-08 Interventions: Drug: sildenafil citrate Subjects will be given 2 types of topical creams, one containing 1% sildenafil |
Completed |
Study Name: A Randomized Trial to Determine if Vitamin B6 Can Prevent Hand and Foot Syndrome in Cancer Patients Treated With Capecitabine Chemotherapy Condition: Hand and Foot Syndrome Date: 2008-10-06 Interventions: Drug: vitamin b6 vitamin b6 10 |
Terminated |
Study Name: Treatment of Hypersensitivity Syndrome (DRESS) With Tegeline® (Human Immunoglobulin) Condition: Drug Hypersensitivity Date: 2007-07-20 Interventions: Drug: Tegeline® 2g/kg in IV on 2days 2g/kg in IV on 4days for patients with renal insufficiency or |